StrataDx
StrataDx is a national CAP-accredited anatomic pathology laboratory specializing in dermatopathology and oral pathology, serving dermatologists, podiatrists, and oral surgeons through molecular diagnostics, PCR testing, and immunohistochemistry services.
- Company typePrivate
- Founded1984
- HeadquartersLexington, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What StrataDx does
StrataDx is a national anatomic pathology laboratory headquartered in Lexington, Massachusetts, providing diagnostic pathology services with a primary focus on dermatopathology and oral pathology, and secondary focus on podiatric, urologic, and general pathology. The company operates a CAP-accredited laboratory offering a comprehensive test menu including immunohistochemistry, 200+ special stains, immunofluorescence, in situ hybridization, and molecular diagnostics. Its proprietary DermSTAT Skin Infection PCR Tests and Onychodystrophy PCR Test with Terbinafine Resistance provide validated molecular diagnostics with reported sensitivity and specificity of 92-100%, outperforming conventional culture methods. The company serves dermatologists, podiatrists, oral surgeons, and dental practitioners, as well as biotechnology, pharmaceutical, academic, and government research programs through clinical research support services.
The company employs 51-100 staff including a roster of board-certified dermatopathologists and oral pathologists trained at leading institutions such as Harvard, Tufts, MD Anderson, and Memorial Sloan Kettering. Operations are supported by an in-house courier network for local specimen pickup, national FedEx/UPS partnerships for broader reach, EMR integration, and a dedicated physician services portal (LKConnect). The business generates revenue primarily through transaction-based diagnostic testing fees billed to insurance (in-network with Aetna, Cigna, Humana, UnitedHealthcare, and various state Medicaid programs) and patient payments for deductibles and co-payments, with additional revenue from per-specimen technical preparation services and clinical research engagements.
StrataDx's corporate history includes its October 2018 acquisition by the parent of Bako Diagnostics, allowing both organizations to operate under common ownership while maintaining separate clinical laboratories. In December 2025, Fulgent Genetics (NASDAQ: FLGT) announced a definitive agreement to acquire StrataDx alongside Bako Diagnostics for approximately $55.5 million; the acquisition was completed in March 2026 for approximately $56.9 million in cash. The acquired business is expected to contribute approximately $50-55 million in annual revenue to Fulgent as part of its expansion into specialty laboratory testing and transformation into a fully integrated precision medicine company.
StrataDx firmographics
Firmographics- Name
- StrataDx
- Legal name
- Strata Pathology Services, Inc.
- Website
- https://stratadx.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- StrataDx is a national CAP-accredited anatomic pathology laboratory specializing in dermatopathology and oral pathology, serving dermatologists, podiatrists, and oral surgeons through molecular diagnostics, PCR testing, and immunohistochemistry services.
- Ownership category
- akta.pro rank
StrataDx industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Testing Laboratories (8734)
- akta.pro primary industry
- Dermatopathology (HLAKACAC)
- akta.pro secondary industry
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)
Keywords
Where StrataDx is headquartered
LocationHeadquarters
- HQ city
- Lexington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
StrataDx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Diagnostic Pathology Testing Services: Clinical and anatomic pathology diagnostic services including dermatopathology, oral pathology, general pathology, and specialized testing such as PCR panels, immunohistochemistry, and immunofluorescence. Revenue generated through insurance billing and patient payments for deductibles and co-payments not covered by contract.
- Technical Preparation Services: Technical histology services for office-based and hospital-based pathology practices including H&E stained slides, special stains, and immunohistochemistry, provided on a per-specimen basis.
- Clinical Research Support: Slide preparation and diagnostic services supporting biotechnology, pharmaceutical, academic, and government research programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Insurance-based diagnostic testing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
StrataDx product offering
Product offeringCore offering
StrataDx is a national anatomic pathology laboratory that provides dermatopathology, oral pathology, and general/urologic pathology diagnostic services to physicians. It offers specialized molecular testing including the DermSTAT PCR skin infection panels and Onychodystrophy PCR test with terbinafine resistance detection, supported by a 200+ immunohistochemistry and special stains menu, technical preparation services, second-opinion consultations, and clinical research support for biotech and pharmaceutical clients.
Product overview
StrataDx is a national diagnostic laboratory providing a comprehensive pathology services portfolio centered on dermatopathology and oral pathology. The core offering consists of dermatopathology services for skin conditions and oral pathology services, supported by specialized testing products including DermSTAT™ Skin Infection PCR Tests for molecular diagnostics and Onychodystrophy PCR Testing with Terbinafine Resistance. Additional services encompass technical preparation (TC/PC), pathology consultations, clinical research support, and vacation coverage. The company operates as a single unified diagnostic laboratory brand rather than a platform-plus-modules architecture, with all services integrated through its CAP-accredited laboratory in Lexington, Massachusetts.
Differentiator
Problem solved
Functional benefit
Products and services
- Dermatopathology Services Diagnostic pathology services for skin conditions including melanocytic lesions, soft tissue lesions, dermatoses, and lymphomas. Provided for dermatologists and dermatology practices by board-certified dermatopathologists with expertise in inflammatory disorders and complex melanocytic lesions.
- Oral Pathology Services Comprehensive oral pathology diagnostic services for oral surgeons and dental practitioners, including biopsy interpretation and oral mucosal evaluation. Affiliated with Brigham and Women's Hospital, Harvard University School of Dental Medicine, and Boston Medical Center.
- DermSTAT Skin Infection PCR Tests Real-time PCR diagnostic panels for skin infections with next-day results, validated at 95-100% sensitivity and specificity. Panels cover bacterial (Staphylococcus aureus, Streptococcus pyogenes, mecA detection), viral (HSV-1, HSV-2, VZV), mycotic (dermatophytes, Candida, Malassezia), scabies, and web space infections. Provided for dermatologists and other physicians.
- Onychodystrophy PCR Test with Terbinafine Resistance PCR-based nail infection diagnostic that detects dermatophytes, saprophytes, yeasts, and Pseudomonas aeruginosa, with reflex terbinafine resistance detection for Trichophyton rubrum and T. mentagrophytes. Proprietary reflex algorithm detects 12 terbinafine-resistant mutations in four reactions. Provided for dermatologists and podiatrists.
- TC/PC (Technical Preparation) Technical histology slide preparation services including routine H&E staining, special stains, and immunohistochemistry, delivered on short notice for office-based and hospital-based pathology practices.
- Pathology Consultations and Second Opinions Second opinion pathology services with board-certified dermatopathologists for challenging cases, providing thorough diagnostic review for physicians seeking expert consultation on complex dermatopathology cases.
- General Pathology / Urologic Pathology Urologic pathology services including prostate biopsy diagnostics using barcode tracking, two-pathologist case review, reports with organ maps and Partin tables, and molecular studies including urine FISH and PCA3 testing.
- Clinical Research Support CAP-accredited full-service laboratory services supporting scientific research including PCR, direct immunofluorescence (DIF), immunohistochemistry (IHC), in situ hybridization (ISH), microbiology, and 200+ special stains. Provided for biotechnology, pharmaceutical, academic, and government research programs.
- Vacation Coverage Backup pathology diagnostic coverage that enables dermatologists and pathology practices to take time off while board-certified dermatopathologists provide accurate diagnoses on inflammatory disorders and complex melanocytic lesions.
- Slow MOHS Pathology services supporting Mohs micrographic surgery, with STAT diagnoses called and faxed to offices within 24 hours of receipt. CAP-approved full-service laboratory staffed around the clock.
- Test Menu (Immunohistochemistry and Special Stains) Comprehensive testing menu including immunofluorescence, immunohistochemistry, in situ hybridization, skin and nail PCR, microbiology, and 200+ special stains performed in-house.
- Alopecia Diagnostic Expertise Specialized diagnosis of all forms of alopecia using a horizontal sectioning technique for specific diagnosis, with board-certified dermatopathologists accessible to clinical teams.
Quantifiable outcome
- DermSTAT Bacterial PCR: 95-100% sensitivity and 95-100% specificity compared to 85-90% sensitivity for culture
- +4 more outcomes
Companies that use StrataDx
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles4 records
StrataDx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
StrataDx partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Bako DiagnosticscoreBako Diagnostics, the parent company and leading U.S. podiatry-focused pathology laboratory, acquired StrataDx in October 2018. The strategic relationship allows both companies to operate more efficiently under common ownership while maintaining separate clinical laboratories and continuing to serve customers independently. The partnership expands market reach for both organizations.
Scale indicators4 records
Expansion highlights7 records
StrataDx competitors and assessment
Company assessmentDirect peers
- Inform Diagnostics (formerly Miraca Life Sciences): Specialty anatomic pathology laboratory with strong dermatopathology franchise and subspecialty expertise. Comparable as a national dermatopathology referral lab using board-certified subspecialists and proprietary test offerings.
- Aurora Diagnostics: Multi-site anatomic pathology laboratory group providing dermatopathology and subspecialty pathology services. Directly comparable as a specialty pathology operator with hospital and dermatology group clients.
- CBLPath: Specialty anatomic and dermatopathology laboratory offering expert consultation and molecular diagnostics. Directly comparable given overlapping dermatopathology focus and similar subspecialist staffing model (a prior StrataDx pathologist worked at CBLPath).
- ProPath: Subspecialty anatomic pathology group with strong dermatopathology, oral pathology, and molecular testing offerings. Comparable as a focused specialty pathology provider serving dermatology and oral surgery practices with a similar consultative service model.
- Bako Diagnostics: Podiatric pathology specialist that was StrataDx's sister company under common ownership before the joint 2026 acquisition by Fulgent Genetics. Operates an analogous specialty pathology model targeting podiatrists and is the most direct comparator in business model and customer base.
Broad incumbents
- Sonic Healthcare USA: International reference laboratory group with U.S. anatomic pathology operations. Comparable via multi-state pathology lab footprint; a former StrataDx pathologist previously worked at Sonic Healthcare USA.
- Laboratory Corporation of America (LabCorp): Major U.S. clinical reference laboratory with anatomic and dermatopathology capabilities through its Dianon and other specialty units. Comparable as a competitor with national payer reach, though dermatopathology is not its focus.
- Quest Diagnostics: Largest U.S. reference laboratory offering dermatopathology and anatomic pathology services. Comparable via overlapping payer contracts, logistics infrastructure, and EMR integration, though dermatopathology is a small piece of a much broader menu.
- AmeriPath (Quest Diagnostics): Subspecialty anatomic pathology subsidiary of Quest Diagnostics. Comparable as a dermatopathology and oral pathology provider with national reach, but operates as part of a much broader reference lab portfolio rather than a focused niche.
Emerging players
- PathologyWatch: Digital dermatopathology platform combining AI-assisted slide analysis with subspecialty reads. Comparable to StrataDx's dermatopathology focus via technology-enabled delivery, representing the digital-native competitive threat to traditional specialty labs.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
StrataDx social profiles
Digital presenceStrataDx compliance and trust
Trust signalCompliance8 records
StrataDx financial estimates
Financial estimateRevenue estimate
Valuation estimate
StrataDx leadership team
Management profileNumber of profiles
Profiles16 records
StrataDx funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
StrataDx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about StrataDx
What does StrataDx do?
StrataDx is a national anatomic pathology laboratory that provides dermatopathology, oral pathology, and general/urologic pathology diagnostic services to physicians. It offers specialized molecular testing including the DermSTAT PCR skin infection panels and Onychodystrophy PCR test with terbinafine resistance detection, supported by a 200+ immunohistochemistry and special stains menu, technical preparation services, second-opinion consultations, and clinical research support for biotech and pharmaceutical clients.
Is StrataDx a public or private company?
StrataDx is a private company. It is classified as corporate owned and is currently acquired.
When was StrataDx founded?
StrataDx was founded in 1984. It employs 51 to 100 people.
Where is StrataDx based?
StrataDx is headquartered in Lexington, United States, in the North America region.
How does StrataDx make money?
Three revenue lines are on record. Diagnostic Pathology Testing Services are the primary driver. The others are technical Preparation Services and clinical Research Support.
Who are StrataDx's main competitors?
Direct peers on record are Inform Diagnostics (formerly Miraca Life Sciences), Aurora Diagnostics, CBLPath, ProPath and Bako Diagnostics. Broad incumbents are Sonic Healthcare USA, Laboratory Corporation of America (LabCorp), Quest Diagnostics and AmeriPath (Quest Diagnostics). PathologyWatch is listed as an emerging player.
Does StrataDx have an API?
No public API is recorded for StrataDx.
What industry is StrataDx in?
StrataDx's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAKACAC, Dermatopathology, with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 621511 and its SIC code is 8734.